Xiaojun Wang (Xuejing Wang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Tandem Mass Spectrometry

Signaling Pathway

Top Venues

Integrative cancer therapies

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaojun Wang, Ling Yin, Mengyin Chai, Buxin Kou, Xiaoni Liu, Xiaojun Wang
Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process. Integrative cancer therapies 23 (2024)
Xiaojun Wang, Ling Yin, Mengyin Chai, Buxin Kou, Xiaoni Liu, Xiaojun Wang
Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process. Integrative cancer therapies 23 (2024)
Xiaojun Wang, Ling Yin, Mengyin Chai, Buxin Kou, Xiaoni Liu, Xiaojun Wang
Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process. Integrative cancer therapies 23 (2024)
Li-Li Zhang, Jianhua Hu, Chunyan Gou, Hua Jin, Chun Zhang, Yang Liu, Yitong Wang, Xiaojun Wang
Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure. Mediators of inflammation 2022 (2022)